#25 – Remdesivir: Ethical and Practical Considerations for Allocation, Tracking, and More

Drs. Julie Ann Justo (@julie_justo), Erin McCreary (@erinmccreary), and Helen Newland (@helennewland) discuss ethical allocation of Emergency Use Authorization remdesivir for patients with COVID-19. Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About Twitter: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp/

Episode metadata supplied by the publisher feed · Published Jun 18, 2020

Embed this episode

Attribution link and audio player

Ready to play

#25 – Remdesivir: Ethical and Practical Considerations for Allocation, Tracking, and More

0:00 1:16:15

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Breakpoints?

This episode is 1 hour and 16 minutes long.

When was this Breakpoints episode published?

This episode was published on June 18, 2020.

Can I download this Breakpoints episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!